Advanced Drug Delivery System (DDS) Nanomedicines Group -
The group has long-term experience in technology, design and development of novel DDS, as nanosized liposomes, nanoparticles and drug-cyclodextrin complexes, for advanced delivery and/or targeting of drugs, vaccines or genetic material. It has experience in advanced techniques for preparation and characterization of DDS and elucidation of interactions between drug molecules, cyclodextrins, lipids and polymers, in order to design the appropriate nanomedicine for each specific therapeutic need. Additionally system performance is evaluated in vitro and in vivo. The group collaborates with a large number of academic and industrial groups in Greece, Europe and USA and receives funding from National sources and European Framework Programs .